# Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors

> **NCT03391791** · — · TERMINATED · sponsor: **Adaptimmune** · enrollment: 2 (actual)

## Conditions studied

- Solid and Hematological Malignancies

## Interventions

- **GENETIC:** Genetically engineered T Cell Receptors

## Key facts

- **NCT ID:** NCT03391791
- **Lead sponsor:** Adaptimmune
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-28
- **Primary completion:** 2018-07-24
- **Final completion:** 2018-07-24
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** terminated after participants were enrolled
- **Last updated:** 2021-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03391791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03391791, "Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03391791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*